Ramsay 1970.

Methods	Allocation: randomly assigned, no further information. Blindness: double (identical capsules). Design: 2 parallel groups. Duration: 12 weeks, single centre. Analysis: intention‐to‐treat. Country: USA.
Participants	Diagnosis: schizophrenics, no further details. N=20. Age: range 29‐55 years, mean 44.4 years. Sex: M 14, F 6. Setting: hospital. History: "chronic" (hospitalised for at least 2 years).
Interventions	1. Trifluoperazine: range 10‐60 mg/day. N=10. 2. Molindone: range 20‐120 mg/day. N=10.
Outcomes	Leaving the study early Side effects: (total number, EPS). Unable to use ‐ Global state: (CGI). Mental state: (BPRS). Behaviour: (NOSIE).
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear